Treatment of Urolithiasis with Medicinal Plant Salvia miltiorrhiza: A Nationwide Cohort Study

Table 1

Characteristics of calculus patients according to use or no use of Danshen.

Variable	Using Danshen in calculus patients				value
	No ()		Yes ()
		%		%
Sex					0.99
Female	4723	55.33	4723	55.33
Male	3813	44.67	3813	44.67
Age group, years					0.99
18–39	3018	35.36	3018	35.36
40–64	4508	52.81	4508	52.81
≥65	1010	11.83	1010	11.83
Mean ± SD (years)	46.42 (14.30)		46.40 (14.29)		0.9157
Baseline comorbidities
Diabetes mellitus	2992	35.05	3339	39.12	<0.0001
Urinary tract infection	4897	57.37	5241	61.4	<0.0001
Hypertension	4402	51.57	4561	53.43	0.0148
Chronic kidney disease	657	7.7	753	8.82	0.0076
Gout	1608	18.84	1811	21.22	0.0001
Duration between diagnosis date of calculus and index, days (mean, median)	1120 (923)		1130 (921)		0.4553

Chi-square test; -test. The mean (median) of follow-up period was 6.27 (5.98) years and 5.09 (4.86) years for cohort group using Danshen and cohort group not using Danshen, separately.